Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy

• Main Authors: Yusri Taha (Author), Hayley Wardle (Author), Adam B. Evans (Author), Ewan R. Hunter (Author), Helen Marr (Author), Wendy Osborne (Author), Matthew Bashton (Author), Darren Smith (Author), Shirelle Burton-Fanning (Author), Matthias L. Schmid (Author), Christopher J. A. Duncan (Author)
• Format: Book
• Published: BMC, 2021-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background There is growing evidence that antibody responses play a role in the resolution of SARS-CoV-2 infection. Patients with primary or secondary antibody deficiency are at increased risk of persistent infection. This challenging clinical scenario is associated with adverse patient out...